| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director | Coo/ CFO | Chief Financial Officer
2 companies
Giraudo Bryan is a Coo/ CFO at GOSS, with reported holdings spanning 2 companies. Recent filings cover 12 purchases and 7 sales. Those positions are worth an estimated $1.3M at current prices.
Our model assigns Giraudo Bryan a strong insider score of 73/100, based on 8 past trades. Over a 12-month horizon, 87.5% of those trades were profitable, with an average 12-month return of +20.6%.
Giraudo Bryan's largest disclosed position is in PTGX as Director, worth about $1.3M. The recent filings there lean toward selling, a net 41,130 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Jun 23, 2020 | GOSS Gossamer Bio, Inc. | Chief Financial Officer | Buy | 2,000 | $12.96 | $25,922.40 | +94.3% | |
| Dec 3, 2019 | PTGX Protagonist Therapeutics, Inc | Director | Buy | 8,000 | $5.70 | $45,620.00 | New | |
| Sep 26, 2019 | GOSS Gossamer Bio, Inc. | Chief Financial Officer | Buy | 1,121 | $16.78 | $18,810.16 | +112.1% | |
| May 30, 2019 | GOSS Gossamer Bio, Inc. | Chief Financial Officer | Buy | 1,000 | $18.70 | $18,700.00 | New | |
| Feb 12, 2019 | GOSS Gossamer Bio, Inc. | Chief Financial Officer | Buy | 6,000 | $16.00 | $96,000.00 | +33.6% | |
| May 16, 2017 | PTGX Protagonist Therapeutics, Inc | Director | Buy | 10,000 | $6.46 | $64,566.00 | New |